Bucindolol (B) single dose pharmacokinetics (PK) in subjects with varying degrees of renal impairment.

被引：0
|
作者：
Ogunremi, A
Swan, S
Gehr, T
Sica, D
Sellers, J
Roberge, P
Ward, D
机构：
[1] Incara Pharmaceut, Res Triangle Pk, NC USA
[2] Total Renal Res Inc, Minneapolis, MN USA
[3] Virginia Commonwealth Univ, Div Nephrol, Richmond, VA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2000年 / 67卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII66
引用
收藏
页码：158 / 158
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics and Safety of a Single Oral Dose of Mirogabalin in Japanese Subjects With Varying Degrees of Renal Impairment
    Kato, Manabu
    Tajima, Naoyuki
    Shimizu, Takako
    Sugihara, Masahiro
    Furihata, Kenichi
    Harada, Kazuhiro
    Ishizuka, Hitoshi
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (01): : 57 - 63
  • [2] Single-dose pharmacokinetics of temocapril and temocapril diacid in subjects with varying degrees of renal impairment
    Sierakowski, B
    Püchler, K
    Witte, PU
    Renneisen, K
    Roots, I
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 53 (3-4) : 215 - 220
  • [3] Single-dose pharmacokinetics of temocapril and temocapril diacid in subjects with varying degrees of renal impairment
    B. Sierakowski
    K. Püchler
    P. U. Witte
    K. Renneisen
    I. Roots
    [J]. European Journal of Clinical Pharmacology, 1997, 53 : 215 - 220
  • [4] Xemilofiban (XEM) single and multiple dose PK and PD in subjects with and without renal impairment.
    Sica, D
    Gehr, T
    Ruddley, J
    Fakhry, I
    Karim, A
    Anders, R
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 236 - 236
  • [5] Bucindolol single dose pharmacokinetics (PK) in subjects with impaired hepatic function.
    Ogunremi, A
    Gehr, T
    Sica, D
    Sellers, J
    Roberge, P
    Ward, D
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 158 - 158
  • [6] Pharmacokinetics of Tapentadol in Subjects With Varying Degrees of Renal Impairment
    Smit, J. W.
    Kleideiter, E.
    Brett, M.
    Lannie, C.
    Mangold, B.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1079 - 1079
  • [7] PHARMACOKINETICS OF FAMCICLOVIR IN SUBJECTS WITH VARYING DEGREES OF RENAL IMPAIRMENT
    BOIKE, SC
    PUE, MA
    FREED, MI
    AUDET, PR
    FAIRLESS, A
    ILSON, BE
    ZARIFFA, N
    JORKASKY, DK
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (04) : 418 - 426
  • [8] Single-dose pharmacokinetics of ibrutinib in subjects with varying degrees of hepatic impairment
    de Jonga, Jan
    Skee, Donna
    Hellemans, Peter
    Jiao, James
    de Vries, Ronald
    Swerts, Dominique
    Lawitz, Eric
    Marbury, Thomas
    Smith, William
    Sukbuntherng, Juthamas
    Mannaert, Erik
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 (01) : 185 - 194
  • [9] Pharmacokinetics (PK) of palifermin in subjects with different degrees of renal impairment
    Gillespie, B
    Zia-Amirhosseini, P
    Salfi, M
    Wang, J
    Robson, R
    Sullivan, JT
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1071 - 1071
  • [10] SINGLE-DOSE PHARMACOKINETICS OF ALP2011 IN SUBJECTS WITH VARIOUS DEGREES OF HEPATIC IMPAIRMENT.
    Michaud, J.
    Fazio, C.
    Boily, S.
    Massicotte, J.
    Sicard, E.
    Lefebvre, M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S77 - S77
12345